TTRX · Turn Therapeutics Inc. · Documents
$12.69
-0.69 (-5.16%)
At close · Sep 11
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our capital resources may not be sufficient to fund operations through at least the next 12 months from the date that the accompanying unaudited condensed consolidated interim financial statements as of June 30, 2026 are issued based on our expected cash needs, which raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$378.01M
Shares
29.79M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-10 | — | |
| 8-K | 2026-09-09 | — | |
| 8-K | 2026-08-18 | 2026-08-13 | |
| 8-K | 2026-08-17 | 2026-08-14 | |
| 8-K | 2026-08-12 | — | |
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-07-28 | — | |
| 8-K | 2026-07-07 | — | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-06-03 | — | |
| 8-K | 2026-06-01 | — | |
| 8-K | 2026-05-27 | — | |
| 8-K | 2026-05-19 | — | |
| 8-K | 2026-05-18 | — | |
| 8-K | 2026-05-11 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-03-31 | — | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-03-24 | 2026-03-23 | |
| Investor Event Transcript | 2026-03-02 | 2026-03-31 | |
| Investor Event Transcript | 2026-02-25 | 2026-03-31 | |
| 8-K | 2026-02-17 | — | |
| 8-K | 2026-02-09 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-07 | — | |
| 8-K | 2025-11-13 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-12 | 2025-11-11 | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-10-30 | — | |
| 8-K | 2025-10-28 | 2025-10-27 | |
| 8-K | 2025-10-22 | — | |
| 8-K | 2025-10-02 | 2025-09-30 |
Showing 1–33 of 33 filings